Skip to main content
Clinical Trials/NCT07246512
NCT07246512CompletedNot Applicable

Comparison Between MTA and TotalFill® BC-RRM Fast Set Putty for Retrograde Filling in Apical Surgery: Randomized Non-inferiority Clinical Trial.

University of Valencia1 site in 1 country110 target enrollmentStarted: February 8, 2024Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
110
Locations
1
Primary Endpoint
Periapical lesion healing assessed by CBCT using 3D PENN criteria.

Study Overview

Brief Summary

The aim of this study is to compare two biomaterials used for retrograde obturation during apical surgery. This surgery is indicated in healthy patients when root canal treatment (endodontics) has failed to eliminate a periapical lesion (a persistent infection in the root of the tooth).

The main question it seeks to answer is:

- Is TotalFill® BC-RRM Fast Set Putty more effective than ProRoot® MTA in periapical surgery in terms of the degree of healing?

The study will include patients who need this type of surgery and meet specific clinical criteria. Each patient will have one of the two materials applied as part of the standard surgical procedure. Subsequently, clinical and radiographic follow-up will be performed to assess the degree of healing of the periapical lesion with a 1-year follow-up.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Triple (Participant, Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Patients over 18 years of age.
  • •Patients giving consent for surgical intervention, for radiographic evaluation with HCT preoperatively and at least one more time after 12 months, and for participation in the study.
  • •Medical history not relevant to the diagnosis and surgical treatment (ASA classes I and II).
  • •Previous non-surgical endodontic treatment or retreatment with clinical and/or radiographic evidence of persistence or recurrence of apical periodontitis. The minimum time since the last non-surgical treatment shall be 6 months.
  • •Teeth not previously treated with periapical surgery.
  • •Lesion less than 10 mm in diameter.
  • •Restorable teeth.
  • •Periodontally sound teeth or teeth with treated periodontal pathology (mobility 1, probing depth < 5mm).
  • •Teeth with no root resorption.

Exclusion Criteria

  • •Teeth with vertical fracture.
  • •Teeth with root perforation.
  • •Lesions associated with an apicomarginal defect.
  • •Tunnel lesions.
  • •Technical errors during surgery that may compromise the outcome.
  • •Lack of integrity of the dentine walls surrounding the retrograde filling detected with the endoscope.
  • •Wound dehiscence.
  • •Postoperative infection.
  • •Follow-up less than 12 months.

Arms & Interventions

BioCeramic Root Repair Material Fast Set Putty (BCRRM)

Experimental

Patients undergoing apical surgery treated with retrograde obturation using BioCeramic Root Repair Material Fast Set Putty (BCRRM).

Intervention: BioCeramic Root Repair Material Fast Set Putty. (Device)

MTA (Mineral Trioxide Aggregate)

Active Comparator

Patients undergoing apical surgery treated with retrograde obturation using Mineral Trioxide Aggregate (MTA).

Intervention: Mineral Trioxide Aggregate (Device)

Outcomes

Primary Outcomes

Periapical lesion healing assessed by CBCT using 3D PENN criteria.

Time Frame: 12 months post-surgery

Periapical healing will be evaluated using cone-beam computed tomography (CBCT) at 12 months after periapical surgery. Lesion volume or dimensions will be measured and the percentage of reduction will be calculated. Based on these measurements, healing will be classified according to the 3D PENN CBCT criteria into complete, limited, uncertain, or unsatisfactory healing. A comparison will be made between ProRoot® MTA versus TotalFill® BC-RRM Fast Set Putty as retrograde filling materials.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

David Peñarrocha Oltra

Associate Professor, PhD

University of Valencia

Study Sites (1)

Loading locations...

Similar Trials